| Structure |
Chemical Name |
CAS |
MF |
 |
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
 |
4-MAR |
|
|
![3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine](/CAS/GIF/1022150-12-4.gif) |
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
1022150-12-4 |
C22H22N6O |
 |
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
 |
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
![(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride](/CAS/20180703/GIF/1701403-10-2.gif) |
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
 |
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
 |
Sugammadex sodium hexabromide intermediate |
|
|
 |
Acetoxy Ceftazidime Intermediate |
|
|
 |
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
![2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-](/CAS/GIF/852148-49-3.gif) |
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
 |
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
 |
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
 |
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
 |
tert-butyl (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oate |
474645-25-5 |
C40H59N3O7 |
 |
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide |
182182-31-6 |
C13H15FN2O2 |
 |
1,1-Dimethylethyl 10,10-dimethyl-8-oxo-3,9-dioxa-2,7-diazaundecanoate |
1243021-74-0 |
C13H26N2O5 |
 |
ethyl 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydroquinoline-4-oxo-3-carboxyla |
99696-21-6 |
C15H12ClF2NO3 |
![(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one](/CAS/GIF/112849-17-9.gif) |
(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one |
112849-17-9 |
C39H66O3Si2 |
![1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/CAS/20180629/GIF/864686-28-2.gif) |
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
864686-28-2 |
C28H33N3O2 |
![(1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20200119/GIF/528587-70-4.gif) |
(1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one |
528587-70-4 |
C11H9FO2 |
 |
Larotaxel intermediate(A-3) |
156294-33-6 |
C31H36O10 |
 |
Flomoxef Intermediate OXA |
|
|
 |
Pantoprazole Sodium Intermediates |
|
|
 |
Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate |
154330-67-3 |
C14H13F2NO3S |
 |
Nevirapine intermediate |
|
|
 |
1,4-bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-dione |
1292836-19-1 |
C16H8Cl2F2N2O6 |
 |
Phosphonic acid, (3-methyloxiranyl)-, (2R-cis)-, compd. with (R)-alpha-methylbenzenemethanamine (1:1), monohydrate (9CI) |
65794-75-4 |
C11H18NO4P |
 |
Canagliflozin Intermediate epimers |
|
|
 |
(S,Z)-5-Amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one |
156732-13-7 |
C32H32N2O |
 |
6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine |
133111-56-5 |
C21H20ClN |
![CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI)](/CAS/20150408/GIF/247068-81-1.gif) |
CarbaMic acid, [(1S)-3-Methyl-1-(2-Methylpropyl)-2-oxo-3-butenyl]-, 1,1-diMethylethyl ester (9CI) |
247068-81-1 |
C14H25NO3 |
 |
Lixivaptan intermediate-IV |
179063-21-9 |
C19H14ClN3O3 |
 |
Sugammadex sodium 7-Bromide intermediates |
|
|
 |
Remdesivir No. 5 intermediate |
|
|
 |
(r)-tert-butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
863453-61-6 |
C8H15NO5S |
 |
Flomoxef Intermediate KDFA |
|
|
![5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole](/CAS/GIF/368890-20-4.gif) |
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole |
368890-20-4 |
C15H12ClF2N3O2S |
![4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one](/CAS/GIF/122584-14-9.gif) |
4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one |
122584-14-9 |
C17H16BrNO4 |
 |
Pemetrexed intermediate |
|
|
 |
1,2,4-butanetriol-3-(1,4,7,10-tetraazacyclododec-1-yl)4hydrochloride |
156077-56-4 |
C12H29ClN4O3 |
 |
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
 |
-- |
93360-08-8 |
C30H27N2O6P |
 |
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
![[402960-19-4],C9H18N2O2, 186.40](/CAS/20180808/GIF/850252-34-5.gif) |
[402960-19-4],C9H18N2O2, 186.40 |
850252-34-5 |
C9H19ClN2O2 |
 |
8-Benzyloxy-5-((R)-2-broMo-1-hydroxyethyl)-1H-quinolinone |
530084-79-8 |
C18H16BrNO3 |
 |
EthanediaMide iMpurity F hcl |
482375-18-8 |
C2H4N2O2 |
![N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/20150408/GIF/CB82682578.gif) |
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1702274-61-0 |
C20H25N5 |
 |
Sugammadex sodium Heptabromide intermediate |
|
|
 |
6-Methyleneandrost-4-ene-3,17-dione |
19457-55-7 |
C20H26O2 |
 |
455284-06-7 |
455284-06-7 |
|
 |
1-Acetyl-4-(4-hydroxyphenyl)piperazine side chain of Ketoconazole |
67914-99-2 |
C13H18N2O3 |
 |
Piperazine, 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)- (acetate) |
906093-30-9 |
C16H22N4O2 |
 |
3,3-Ethylenedioxy-17β-cyano-17α-trimethylsilyloxyestra-5(10)9(11)-diene |
54690-63-0 |
C24H35NO3Si |
 |
Triazinate |
41191-04-2 |
C23H31ClN6O5S |
 |
Prostaglandin E2-biotin |
|
C35H58N4O6S |
 |
Side chain of Cefotetan |
955010-42-1 |
C10H13NO5S2 |
 |
DELTA12-PROSTAGLANDIN J2 |
87893-54-7 |
C20H30O4 |
 |
Cefaloram |
859-07-4 |
C18H18N2O6S |
 |
Cefetrizole |
65307-12-2 |
C16H15N5O4S3 |
 |
11-DEOXY-13,14-DIHYDRO-15-KETO-11BETA,16CHI-CYCLOPROSTAGLANDIN E2 |
109826-53-1 |
C20H30O4 |
 |
9-OXO-11ALPHA,15S-DIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID |
802-31-3 |
C20H30O5 |
![1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE](/CAS/GIF/197897-11-3.gif) |
1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE |
197897-11-3 |
C14H14IN5O3S |
 |
PROSTAGLANDIN F1ALPHA |
745-62-0 |
C20H36O5 |
 |
D-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-β-(S)-tert-butoxybutyric acid |
79276-23-6 |
C15H25N3O6 |
 |
Cefovecin |
234096-34-5 |
C17H19N5O6S2 |
 |
17-PHENYL TRINOR PROSTAGLANDIN E2 |
38315-43-4 |
C23H30O5 |
 |
PROSTAGLANDIN D2 |
41598-07-6 |
C20H32O5 |
 |
9ALPHA,15S-DIHYDROXY-11-OXO-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
211105-29-2 |
C20H28D4O5 |
 |
Prostaglandin E synthase 3 (PTGES3) Antibody |
|
|
 |
13,14-dihydro Prostaglandin F2a |
|
|
 |
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
 |
20-hydroxy Prostaglandin F2a |
|
|
![5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide](/CAS/GIF/89729-09-9.gif) |
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
![5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester](/CAS/GIF/147125-14-2.gif) |
5-(4-{2-[5-(tert-Butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-hexanoic acid ethyl ester |
147125-14-2 |
C33H56O3Si |
 |
Sterolazole intermediate |
|
|
![(2S)-2-(2,6-Dichlorophenyl)-1-[(1R)-1-phenylethyl]-4-imidazolidinone](/CAS/GIF/1004754-99-7.gif) |
(2S)-2-(2,6-Dichlorophenyl)-1-[(1R)-1-phenylethyl]-4-imidazolidinone |
1004754-99-7 |
C17H16Cl2N2O |
 |
Lixivaptan intermediate-V |
168079-19-4 |
C19H16ClN3O |
 |
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
 |
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
 |
Carbamazepine intermediate |
|
|
![3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one](/CAS/GIF/1214741-21-5.gif) |
3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one |
1214741-21-5 |
C12H19NO3 |
 |
(S)-2-Amino-5-methoxytetralin Hydrochloride |
58349-17-0 |
C11H15NO.HCl |
![BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE](/CAS/GIF/518047-98-8.gif) |
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
![2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine](/CAS2/GIF/181210-18-4.gif) |
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
 |
Flomoxef Intermediate NaMT |
|
|
![2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid](/) |
2-[4-[(1-methoxycarbonyl-2-oxocyclopentyl)methyl]phenyl]propanoic acid |
|
|
 |
Silicone intermediate |
|
|
 |
BORTEZOMIB-PINANEDIOL |
205393-22-2 |
C29H39BN4O4 |
![a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate](/CAS/GIF/114869-97-5.gif) |
a-D-Glucopyranoside,methyl 4-O-[2-O-acetyl-6-methyl-3-O-(phenylmethyl)-a-L-idopyranuronosyl]-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-,6-acetate |
114869-97-5 |
C40H47NO15 |
 |
RebaMipide interMediate product |
169809-59-0 |
C19H16ClN2NaO4 |
 |
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
C29H28ClNO2 |
 |
N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide |
122584-18-3 |
C17H18BrNO4 |
 |
5'-Methoxylaudanosine |
24734-71-2 |
C22H29NO5 |
 |
(R)-1-Z-2-TERT-BUTYL-3-METHYL-4-IMIDAZOLIDINONE |
119906-46-6 |
C16H22N2O3 |
![3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile](/CAS/20180601/GIF/941688-05-7.gif) |
3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
941688-05-7 |
C17H18N6 |
 |
Lumacaftor Intermediate |
936727-68-3 |
C17H13ClF2N2O3 |
![tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate](/CAS/20200401/GIF/1350636-75-7.gif) |
tert-butyl N-[(1R,3R,4R)-3-hydroxy-4-sulfanylcyclohexyl]carbamate |
1350636-75-7 |
C11H21NO3S |
![3-[2-(3,4-Dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-on](/CAS/GIF/15462-91-6.gif) |
3-[2-(3,4-Dimethoxybenzoyl)-4,5-dimethoxyphenyl]pentan-2-on |
15462-91-6 |
C22H26O6 |
![α-[4-[2-(Diethylamino)ethoxy]phenyl]-α-phenylphenethylalkohol](/CAS/GIF/73404-00-9.gif) |
α-[4-[2-(Diethylamino)ethoxy]phenyl]-α-phenylphenethylalkohol |
73404-00-9 |
C26H31NO2 |